ConductScience.org, home

Paper25589056

An update on photodynamic therapies in the treatment of onychomycosis.

Simmons BJ and 3 others. J Eur Acad Dermatol Venereol, 2015. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. An update on photodynamic therapies in the treatment of onychomycosis. Papers, record 25589056. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25589056

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An update on photodynamic therapies in the treatment of onychomycosis.
PubMed
Journal
J Eur Acad Dermatol Venereol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.49
iCite
Revised in PubMed
2015-06-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Simmons BJB Jhttps://orcid.org/0000-0003-0862-0055
2Griffith RDR D
3Falto-Aizpurua LAL Ahttps://orcid.org/0000-0002-5553-4507
4Nouri KK

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OnychomycosisMajor topic
PhotochemotherapyMajor topic
Photosensitizing AgentsMajor topic
Humans
Quality of Life
Treatment Outcome

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
41913886Keratinizing Squamous Cell Carcinoma Masquerading as Basal Cell Carcinoma Constituting a Diagnostic Pitfall: A Case Report With Etiopathogenetic Discourse and Mohs Micrographic Surgical Management.Cureus2026https://conductscience.org/library/papers/41913886PubMed
41884392An Overview of the Treatment of Onychomycosis in Patients with Diabetes: Current Pharmacological and Non-Pharmacological Options.Clin Cosmet Investig Dermatol2026https://conductscience.org/library/papers/41884392PubMed
39720526Therapeutic potential of 5-aminolevulinic acid in metabolic disorders: Current insights and future directions.iScience2024https://conductscience.org/library/papers/39720526PubMed
38093835Novel Henna-Related Naphthazarine Photosensitizers for an Effective Photodynamic Therapy of Onychomycosis.ACS Pharmacol Transl Sci2023https://conductscience.org/library/papers/38093835PubMed
36422019Metagenomics of Toenail Onychomycosis in Three Victorian Regions of Australia.J Fungi (Basel)2022https://conductscience.org/library/papers/36422019PubMed
35761978Photodynamic Therapy for the Treatment of Fungal Infections.Infect Drug Resist2022https://conductscience.org/library/papers/35761978PubMed
35745641Combination of Photodynamic Therapy and Oral Antifungals for the Treatment of Onychomycosis.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35745641PubMed
34835655Photosensitizers Mediated Photodynamic Inactivation against Fungi.Nanomaterials (Basel)2021https://conductscience.org/library/papers/34835655PubMed
34705261Photodynamic disinfection and its role in controlling infectious diseases.Photochem Photobiol Sci2021https://conductscience.org/library/papers/34705261PubMed
34165875Aloe-emodin-mediated antimicrobial photodynamic therapy against dermatophytosis caused by Trichophyton rubrum.Microb Biotechnol2022https://conductscience.org/library/papers/34165875PubMed
31092174Novel Drug Delivery Strategies for the Treatment of Onychomycosis.Pharm Nanotechnol2019https://conductscience.org/library/papers/31092174PubMed
30042327Challenges and Opportunities in the Management of Onychomycosis.J Fungi (Basel)2018https://conductscience.org/library/papers/30042327PubMed
29376897Onychomycosis: A Review.J Fungi (Basel)2015https://conductscience.org/library/papers/29376897PubMed
28232927Photodynamic Therapy and Skin Appendage Disorders: A Review.Skin Appendage Disord2017https://conductscience.org/library/papers/28232927PubMed
27885523A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis.Lasers Med Sci2017https://conductscience.org/library/papers/27885523PubMed
27339057Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer.Lasers Med Sci2016https://conductscience.org/library/papers/27339057PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25589056

GET https://conductscience.org/api/papers/v1/25589056/authors